Spoken Alpha
CABA
Cabaletta Bio, Inc.
Overview
Cabaletta Bio, Inc is a Healthcare company operating in Biotechnology with a $432.3M market cap.
Most recent reported earnings: Q3 FY2026 (Nov 8, 2026).
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from SEC 10-K filing, 2026-08-30.
Transcripts
Recent earnings calls
No earnings calls indexed for CABA yet
We index calls for roughly 3,000 US-listed companies. If you'd like us to add CABA, reply to your welcome email and we'll prioritize it.
History
Earnings history
- Q3 FY20262026-11-08EPS— vs $-0.33—Rev— vs ——EODHD
- Q2 FY20262026-08-12EPS$-0.34 vs $-0.37+8.1%Rev$0 vs ——EODHD
- Q1 FY20262026-05-13EPS$-0.39 vs $-0.390.0%Rev$0 vs ——EODHD
- Q4 FY20252026-03-11EPS$-0.40 vs $-0.46+12.7%Rev$0 vs ——EODHD
- Q3 FY20252025-11-09EPS$-0.44 vs $-0.46+4.3%Rev$0 vs ——EODHD
- Q2 FY20252025-08-06EPS$-0.73 vs $-0.71-2.8%Rev$0 vs ——EODHD
- Q1 FY20252025-05-14EPS$-0.71 vs $-0.67-6.0%Rev$0 vs ——EODHD
- Q4 FY20242025-03-18EPS$-0.65 vs $-0.63-3.8%Rev$1.6M vs ——EODHD
- Q3 FY20242024-11-13EPS$-0.62 vs $-0.61-1.6%Rev$0 vs ——EODHD
- Q2 FY20242024-08-07EPS$-0.56 vs $-0.57+1.8%Rev$0 vs ——EODHD
- Q1 FY20242024-05-14EPS$-0.51 vs $-0.48-6.3%Rev$0 vs ——EODHD
- Q4 FY20232024-03-20EPS$-0.46 vs $-0.39-17.9%Rev$4.0M vs ——EODHD
- Q3 FY20232023-11-08EPS$-0.37 vs $-0.42+11.9%Rev$0 vs ——EODHD
- Q2 FY20232023-08-09EPS$-0.37 vs $-0.42+11.9%Rev$0 vs ——EODHD
- Q1 FY20232023-05-10EPS$-0.45 vs $-0.47+4.3%Rev$0 vs ——EODHD
- Q4 FY20222023-03-15EPS$-0.52 vs $-0.45-15.6%Rev$0 vs ——EODHD
- Q3 FY20222022-11-09EPS$-0.39 vs $-0.47+17.0%Rev$0 vs ——EODHD
- Q2 FY20222022-08-10EPS$-0.45 vs $-0.50+10.0%Rev$0 vs ——EODHD
- Q1 FY20222022-05-11EPS$-0.45 vs $-0.53+15.1%Rev$0 vs ——EODHD
- Q4 FY20212022-03-16EPS$-0.49 vs $-0.60+18.3%Rev$0 vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-11-08 | — | $-0.33 | — | — | — | — | EODHD |
| Q2 FY2026 | 2026-08-12 | $-0.34 | $-0.37 | +8.1% | $0 | — | — | EODHD |
| Q1 FY2026 | 2026-05-13 | $-0.39 | $-0.39 | 0.0% | $0 | — | — | EODHD |
| Q4 FY2025 | 2026-03-11 | $-0.40 | $-0.46 | +12.7% | $0 | — | — | EODHD |
| Q3 FY2025 | 2025-11-09 | $-0.44 | $-0.46 | +4.3% | $0 | — | — | EODHD |
| Q2 FY2025 | 2025-08-06 | $-0.73 | $-0.71 | -2.8% | $0 | — | — | EODHD |
| Q1 FY2025 | 2025-05-14 | $-0.71 | $-0.67 | -6.0% | $0 | — | — | EODHD |
| Q4 FY2024 | 2025-03-18 | $-0.65 | $-0.63 | -3.8% | $1.6M | — | — | EODHD |
| Q3 FY2024 | 2024-11-13 | $-0.62 | $-0.61 | -1.6% | $0 | — | — | EODHD |
| Q2 FY2024 | 2024-08-07 | $-0.56 | $-0.57 | +1.8% | $0 | — | — | EODHD |
| Q1 FY2024 | 2024-05-14 | $-0.51 | $-0.48 | -6.3% | $0 | — | — | EODHD |
| Q4 FY2023 | 2024-03-20 | $-0.46 | $-0.39 | -17.9% | $4.0M | — | — | EODHD |
| Q3 FY2023 | 2023-11-08 | $-0.37 | $-0.42 | +11.9% | $0 | — | — | EODHD |
| Q2 FY2023 | 2023-08-09 | $-0.37 | $-0.42 | +11.9% | $0 | — | — | EODHD |
| Q1 FY2023 | 2023-05-10 | $-0.45 | $-0.47 | +4.3% | $0 | — | — | EODHD |
| Q4 FY2022 | 2023-03-15 | $-0.52 | $-0.45 | -15.6% | $0 | — | — | EODHD |
| Q3 FY2022 | 2022-11-09 | $-0.39 | $-0.47 | +17.0% | $0 | — | — | EODHD |
| Q2 FY2022 | 2022-08-10 | $-0.45 | $-0.50 | +10.0% | $0 | — | — | EODHD |
| Q1 FY2022 | 2022-05-11 | $-0.45 | $-0.53 | +15.1% | $0 | — | — | EODHD |
| Q4 FY2021 | 2022-03-16 | $-0.49 | $-0.60 | +18.3% | $0 | — | — | EODHD |
Source: EODHD. CABA reported actuals as published; sparse fields render as —.
Top executives
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
- Steven NichtbergerCEO6 yr 11 mono recorded callsCurrent
- Anup MardaCFO6 yr 11 mono recorded callsCurrent
- Gwendolyn BinderPresident1 yr 6 mono recorded callsCurrent
- Steven GavelChief Commercial Officer8 mono recorded callsCurrent
- Arun DasChief Business Officer4 yr 8 mono recorded callsCurrent
- David D ChangChief Medical Officer6 yr 11 mono recorded callsCurrent
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for CABA.
$ curl https://api.spokenalpha.com/v1/companies/CABAFAQ
Frequently asked about CABA
Where can I find Cabaletta Bio, Inc.'s (CABA) earnings call transcripts?
Spoken Alpha indexes CABA's earnings call transcripts at https://spokenalpha.com/companies/CABA. Each call links to attributed speakers and parsed analyst Q&A. Cabaletta Bio, Inc.'s own investor relations page is at https://www.cabalettabio.com/investors.
What sector is CABA in?
Cabaletta Bio, Inc. (CABA) operates in the Healthcare sector (Biotechnology industry).